Anti-Toxoplasma effects of dapsone alone and combined with pyrimethamine
- 1 February 1991
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 35 (2), 252-255
- https://doi.org/10.1128/aac.35.2.252
Abstract
The efficacy of dapsone alone or combined with pyrimethamine against Toxoplasma gondii was investigated experimentally. For in vitro studies, a sensitive immunoassay was used for assessment of Toxoplasma growth in tissue cultures; dapsone was found to have a significant inhibitory effect at a concentration of 0.5 micrograms/ml in the cultures, and the 50% inhibitory concentration was estimated to be 0.55 micrograms/ml. When pyrimethamine and dapsone were combined, an important synergistic effect which was associated with morphological alterations of the parasites was observed. In vivo studies were performed in a murine model of acute toxoplasmosis in which a tissue culture method was used to estimate the parasite burden in the blood, lungs, and brains of infected mice. Dapsone alone, which was administered at 100 mg/kg/day for 10 days from day 1 after infection, was unable to prevent parasite dissemination and only delayed the time to death of treated mice compared with the time of death of untreated controls. When dapsone and pyrimethamine (18.5 mg/kg/day) were administered in combination from day 4 after infection, parasites were cleared from blood and organs within 6 days, but relapses were observed 15 days after the cessation of therapy. When treatment was started at day 1 after infection, 100% of mice survived and relapses were not observed, suggesting a good efficacy of this combination for preventive therapy.This publication has 15 references indexed in Scilit:
- In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected miceAntimicrobial Agents and Chemotherapy, 1990
- Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase.JCI Insight, 1990
- In vitro effects of folate inhibitors on Toxoplasma gondiiAntimicrobial Agents and Chemotherapy, 1989
- Dapsone, Trimethoprim, and Sulfamethoxazole Plasma Levels during Treatment of Pneumocystis Pneumonia in Patients with the Acquired Immunodeficiency Syndrome (AIDS)Annals of Internal Medicine, 1989
- Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndromeAntimicrobial Agents and Chemotherapy, 1988
- Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumoniaAntimicrobial Agents and Chemotherapy, 1988
- The pharmacokinetics of dapsone after oral administration to healthy volunteers.British Journal of Clinical Pharmacology, 1986
- Clinical Pharmacokinetics of DapsoneClinical Pharmacokinetics, 1986
- Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitisAntimicrobial Agents and Chemotherapy, 1984
- Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.British Journal of Clinical Pharmacology, 1980